These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 37159202)

  • 1. Changes in Minoxidil Prescribing After Media Attention About Oral Use for Hair Loss.
    Goodwin Cartwright BM; Wang M; Rodriguez P; Stewart S; Worsham CM; Stucky N; Jena AB
    JAMA Netw Open; 2023 May; 6(5):e2312477. PubMed ID: 37159202
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased prescriptions of oral minoxidil after a high-profile newspaper article about its benefits for hair loss.
    Mirmirani P; Young PA; Vanderweil SG; Vanchinathan V; Click JW; McCleskey PE
    Dermatol Online J; 2023 Aug; 29(4):. PubMed ID: 37921823
    [No Abstract]   [Full Text] [Related]  

  • 3. Oral minoxidil treatment for hair loss: A review of efficacy and safety.
    Randolph M; Tosti A
    J Am Acad Dermatol; 2021 Mar; 84(3):737-746. PubMed ID: 32622136
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Female pattern hair loss: a pilot study investigating combination therapy with low-dose oral minoxidil and spironolactone.
    Sinclair RD
    Int J Dermatol; 2018 Jan; 57(1):104-109. PubMed ID: 29231239
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The efficacy of 3% minoxidil vs. combined 3% minoxidil and Korean red ginseng in treating female pattern alopecia.
    Ryu HJ; Yoo MG; Son SW
    Int J Dermatol; 2014 Jun; 53(6):e340-2. PubMed ID: 24451023
    [No Abstract]   [Full Text] [Related]  

  • 6. [Effect of minoxidil on hair growth in androgenic alopecia in women].
    Brzezińska-Wcisło L
    Pol Merkur Lekarski; 2002 Sep; 13(75):208-11. PubMed ID: 12474572
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of female pattern hair loss with a combination of spironolactone and minoxidil.
    Hoedemaker C; van Egmond S; Sinclair R
    Australas J Dermatol; 2007 Feb; 48(1):43-5. PubMed ID: 17222303
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The potential role of minoxidil in the hair transplantation setting.
    Avram MR; Cole JP; Gandelman M; Haber R; Knudsen R; Leavitt MT; Leonard RT; Puig CJ; Rose PT; Vogel JE; Ziering CL;
    Dermatol Surg; 2002 Oct; 28(10):894-900; discussion 900. PubMed ID: 12410672
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A review of the treatment of male pattern hair loss.
    York K; Meah N; Bhoyrul B; Sinclair R
    Expert Opin Pharmacother; 2020 Apr; 21(5):603-612. PubMed ID: 32066284
    [No Abstract]   [Full Text] [Related]  

  • 10. Minoxidil Sulfotransferase Enzyme (SULT1A1) genetic variants predicts response to oral minoxidil treatment for female pattern hair loss.
    Ramos PM; Gohad P; McCoy J; Wambier C; Goren A
    J Eur Acad Dermatol Venereol; 2021 Jan; 35(1):e24-e26. PubMed ID: 32567076
    [No Abstract]   [Full Text] [Related]  

  • 11. Minoxidil in the treatment of androgenetic alopecia.
    Goren A; Naccarato T
    Dermatol Ther; 2018 Sep; 31(5):e12686. PubMed ID: 30155952
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 5% Minoxidil: treatment for female pattern hair loss.
    Gupta AK; Foley KA
    Skin Therapy Lett; 2014; 19(6):5-7. PubMed ID: 25807073
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Minoxidil: a comprehensive review.
    Gupta AK; Talukder M; Venkataraman M; Bamimore MA
    J Dermatolog Treat; 2022 Jun; 33(4):1896-1906. PubMed ID: 34159872
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Topical minoxidil therapy for hair regrowth.
    Rumsfield JA; West DP; Fiedler-Weiss VC
    Clin Pharm; 1987 May; 6(5):386-92. PubMed ID: 3311578
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized, double-blind controlled study of the efficacy and safety of topical solution of 0.25% finasteride admixed with 3% minoxidil vs. 3% minoxidil solution in the treatment of male androgenetic alopecia.
    Suchonwanit P; Srisuwanwattana P; Chalermroj N; Khunkhet S
    J Eur Acad Dermatol Venereol; 2018 Dec; 32(12):2257-2263. PubMed ID: 29972712
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of female androgenetic alopecia with minoxidil 2%.
    Whiting DA; Jacobson C
    Int J Dermatol; 1992 Nov; 31(11):800-4. PubMed ID: 1428436
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Topical minoxidil for androgenetic alopecia: optimizing the chance for success by appropriate patient selection.
    DeVillez RL
    Dermatologica; 1987; 175 Suppl 2():50-3. PubMed ID: 3691914
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of Topical Combination of 0.25% Finasteride and 3% Minoxidil Versus 3% Minoxidil Solution in Female Pattern Hair Loss: A Randomized, Double-Blind, Controlled Study.
    Suchonwanit P; Iamsumang W; Rojhirunsakool S
    Am J Clin Dermatol; 2019 Feb; 20(1):147-153. PubMed ID: 30206824
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of topical minoxidil therapy for androgenetic alopecia in women.
    Jacobs JP; Szpunar CA; Warner ML
    Int J Dermatol; 1993 Oct; 32(10):758-62. PubMed ID: 8225725
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Topical minoxidil in male pattern baldness: effects of discontinuation of treatment.
    Olsen EA; Weiner MS
    J Am Acad Dermatol; 1987 Jul; 17(1):97-101. PubMed ID: 3301926
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.